NCT00669812View on ClinicalTrials.gov

High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2008

Conditions
LymphomaSmall Intestine Cancer
Interventions
DRUG

carmustine

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

doxorubicin hydrochloride

DRUG

epirubicin hydrochloride

DRUG

etoposide

DRUG

ifosfamide

DRUG

melphalan

DRUG

methotrexate

DRUG

prednisolone

DRUG

vincristine sulfate

PROCEDURE

autologous hematopoietic stem cell transplantation

PROCEDURE

biopsy

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (1)

NE1 4LP

RECRUITING

Sir James Spence Institute of Child Health at Royal Victoria Infirmary, Newcastle upon Tyne

Sponsors

Lead Sponsor

Cancer Research UK
All Listed Sponsors
lead

Cancer Research UK

OTHER

NCT00669812 - High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | Biotech Hunter | Biotech Hunter